MK-4409

MK-4409

Clinical data
ATC code	None
Legal status
Legal status	US: Investigational New Drug
Identifiers
IUPAC name 2-[5-[5-(5-Chloropyridin-2-yl)sulfanyl-2-(4-fluorophenyl)-1,3-oxazol-4-yl]pyridin-2-yl]propan-2-ol
CAS Number	1207745-58-1 Y
PubChem CID	53341130
ChemSpider	25069631
UNII	77GX6MU9ZL
ChEMBL	ChEMBL1812717
Chemical and physical data
Formula	C22H17FN3O2S
Molar mass	406.46 g·mol−1
3D model (JSmol)	Interactive image
SMILES c3nc(C(O)(C)C)ccc3-c1nc(-c4ccc(F)cc4)oc1Sc(nc2)ccc2Cl
InChI InChI=1S/C22H17ClFN3O2S/c1-22(2,28)17-9-5-14(11-25-17)19-21(30-18-10-6-15(23)12-26-18)29-20(27-19)13-3-7-16(24)8-4-13/h3-12,28H,1-2H3 Key:DBZMCSVIITXLCC-UHFFFAOYSA-N

MK-4409 is an experimental drug which acts as a potent and selective inhibitor of the enzyme fatty acid amide hydrolase (FAAH), with an IC₅₀ of 11 nM, and both analgesic and antiinflammatory effects in animal studies. It was studied for the treatment of neuropathic pain and progressed to early stage human clinical trials by 2009.

See also

• LY-2183240
• URB-597
• PF-3845
• BIA 10-2474

External links

• "MK 4409". Adis Insight. Springer Nature Switzerland AG.